Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea

ObjectiveTo compare the incidence and survival rates of primary ovarian clear cell carcinoma (OCCC) and ovarian serous carcinoma (OSC) from a nationwide collected database.MethodsWe extracted information of patients with primary OCCC and OSC from the Korea Central Cancer Registry recorded between 19...

Descripció completa

Dades bibliogràfiques
Autors principals:	Se Ik Kim, Hyeong In Ha, Kyung Jin Eoh, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
Format:	Article
Idioma:	English
Publicat:	Frontiers Media S.A. 2022-04-01
Col·lecció:	Frontiers in Oncology
Matèries:	ovarian cancer histologic subtype clear cell carcinoma serous carcinoma incidence survival
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2022.874037/full

Ítems similars

FREQUENCY OF NAPSIN A POSITIVITY IN OVARIAN CLEAR CELL CARCINOMA AND SEROUS CARCINOMA
per: Zara Saeed, et al.
Publicat: (2018-08-01)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
per: Huimei Zhou, et al.
Publicat: (2020-04-01)

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
per: Young Shin Chung, et al.
Publicat: (2019-04-01)

Testicular serous carcinoma of ovarian epithelial type
per: Chang-Hong Yeh, et al.
Publicat: (2017-06-01)

Differential expression of estrogen receptor subtypes in ovarian high‐grade serous carcinoma and clear cell carcinoma
per: Daiken Osaku, et al.
Publicat: (2021-10-01)

Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
per: Kosuke Kanno, et al.
Publicat: (2024-08-01)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
per: Maho Shimizu, et al.
Publicat: (2021-06-01)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
per: Manon Lefebvre, et al.
Publicat: (2023-01-01)

Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
per: Jung Mi Byun, et al.
Publicat: (2023-01-01)

Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database
per: Xiaoduo Li, et al.
Publicat: (2021-02-01)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
per: Ruifen Dong, et al.
Publicat: (2016-09-01)

Nomograms of Combining MRI Multisequences Radiomics and Clinical Factors for Differentiating High-Grade From Low-Grade Serous Ovarian Carcinoma
per: Cuiping Li, et al.
Publicat: (2022-06-01)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
per: Renan Ribeiro e Ribeiro, et al.
Publicat: (2021-05-01)

The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature
per: Paulina Haight, et al.
Publicat: (2021-05-01)

Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin
per: Zachary Raizman, et al.
Publicat: (2017-05-01)

Treatment results and prognostic factors of clear cell ovarian carcinomas and ovarian carcinomas with clear cell component
per: M. D. Ahmedova, et al.
Publicat: (2014-07-01)

Primary ovarian serous carcinomas with extensive squamous differentiation: a case report and literature review
per: Yao Sun, et al.
Publicat: (2021-05-01)

Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
per: Eun-Gyeong Lee, et al.
Publicat: (2023-09-01)

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
per: Hyeong In Ha, et al.
Publicat: (2021-09-01)

Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin
per: Akira Nishijima, et al.
Publicat: (2024-08-01)

Acute Presentation of Large Size Clear Cell Ovarian Carcinoma as Double Torsed Ovarian Tumor
per: Diana Bužinskienė, et al.
Publicat: (2022-01-01)

Correction of Funding information: The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea Central Cancer Registry
per: Hyeong In Ha, et al.
Publicat: (2022-07-01)

Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas
per: Huann-Cheng Horng, et al.
Publicat: (2014-12-01)

Fallopian tube origin of supposed ovarian high-grade serous carcinomas
per: Patricia Martini Diniz, et al.
Publicat: (2011-01-01)

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
per: Ling Zhou, et al.
Publicat: (2021-05-01)

Immunoexpression of p53 and p16 in Low and High-grade Serous Ovarian Cancer: A Cross-sectional Study
per: Ranajit Mandal, et al.
Publicat: (2023-11-01)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
per: Li Jie, et al.
Publicat: (2012-03-01)

Ovarian clear cell carcinoma with bilateral breast metastasis
per: Aashita, et al.
Publicat: (2023-01-01)

A Rare Case of Serous Papillary Ovarian Epithelial Type Carcinoma in Testis: A Rare Testicular Neoplasm
per: Alireza Abdollahi, et al.
Publicat: (2019-11-01)

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
per: Martin Köbel, et al.
Publicat: (2023-05-01)

Clear cell endometrial carcinoma precursors: presentation of two cases and diagnostic issues
per: Angela Santoro, et al.
Publicat: (2021-10-01)

Knowledge and Anxiety Related to Hereditary Ovarian Cancer in Serous Ovarian Cancer Patients
per: Sang Hee Lee, et al.
Publicat: (2019-12-01)

Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas
per: Nayar Musfera Abdul Masjeed, et al.
Publicat: (2017-08-01)

Intra-Tumoral Lymphocytic Infiltration Is Associated with Favorable Prognosis in Suboptimal Surgery in High-Grade Serous Ovarian Carcinoma
per: Hiroshi Harada, et al.
Publicat: (2025-02-01)

Ovarian high-grade serous carcinoma with estrogenic manifestations in a postmenopausal woman: A case report
per: Akihiro Takeda, et al.
Publicat: (2023-03-01)

Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma
per: Ashlee L. Smith, et al.
Publicat: (2013-10-01)

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
per: Takuma Ohsuga, et al.
Publicat: (2017-08-01)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
per: Tsukuru Amano, et al.
Publicat: (2021-01-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
per: I. S. Shponka, et al.
Publicat: (2020-04-01)

Synchronous Primary Serous Carcinoma of the Endometrium and Bilateral Ovaries
per: Shivali Sehgal, et al.
Publicat: (2017-07-01)